Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

Launched by EMS · Dec 19, 2012

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed Informed Consent;
• • Adults Male and Female ≥ 18 years old;
• • Obesity (BMI ≥ 30kg/m2 or ≥ 27 Kg/m2 with associate risk);
• Exclusion Criteria:
• • Pregnancy and Lactation or women without effective contraception;
• • Relevant clinical diseases;
• • Obesity associated to genetic syndrome;
• • Decompensated Diabetes;
• • Psychiatric disorders;
• • Alimentary disorders;
• • Use of: anorectics, herbal weight loss and/or constipation and laxatives, in the past 30 days;
• • Patients using cyclosporine or amiodarone;
• • Patients with bowel disease;
• • Prior bariatric surgery;
• • Anemia;
• • Hemoglobinopathies and coagulopathy;
• • History of cancer in the past five years;
• • Use of corticosteroids, oral or injectable, in the last 30 days.